Weng Tao, MD, PhD
Head of Regulatory Affairs
Dr. Tao is a seasoned executive with over 30 years of experience in the biotech industry. Prior to joining OncoC4, Dr. Tao was the head of regulatory affairs at OncoImmune. Dr. Tao also co-founded Neurotech USA in 2000, and served as its Chief Scientific Officer, leading the development of their Encapsulated Cell Technology (ECT) from lab concept to clinical testing for a wide range of currently untreatable or under treated diseases, including RP, GA, MacTel and wet AMD. Dr. Tao then went on to start her own biotech consulting company, Tao Consulting. She has broad experience in translational research, clinical development, CMC and regulatory affairs with a proven track record in team building, project management and problem solving utilizing multidisciplinary approaches.